Sarepta Therapeutics, a leader in DMD treatments, is seen as a strong acquisition target due to its innovative pipeline and impressive revenue growth. With the pharmaceutical industry focusing on rare diseases, SRPT presents an attractive investment opportunity for potential growth and wealth creation.